“…Thus, a direct action of the drugs on the beta cells emerges as the most likely cause of these observations. In support of this conclusion, the foliowing evidence may be cited: carbutamide and glibenclamide lower the ATP [46] and the glucose-6-phosphate content of isolated islets [46,47], even as glibenclamide and tolbutamide increase their oxygen consumption and laetate production [33,48]. Thus, although there is some exddenee to the contrary [37,49], the sulfonylureas may uncouple oxidative phosphorylation in the islets, as they appear to do in liver, diaphragm and adipose tissue [50,51].…”